Federico Cesarino
CEO & Co-Founder
Former Technical Program Manager Lead at Google with 15 years of experience across AI, UX research, data operations, and product strategy

Clinical intelligence, grounded in evidence
Ask a clinical question and Helios searches the published literature for an answer you can inspect and apply with judgement.
Asking needs a free account, 100 questions a month. Sending your question will ask you to sign in.
Helios is powered by AI. Always apply clinical judgement and consult the referenced sources
Is adjuvant chemotherapy indicated for stage IC expansile mucinous ovarian carcinoma?
For stage IC expansile mucinous ovarian carcinoma the evidence for adjuvant chemotherapy is weak. Expansile tumours have a markedly better prognosis than infiltrative ones, with five-year survival above 90% after complete staging1. The ESMO-ESGO consensus lists platinum-based chemotherapy as an option with a grade of III, B2: level III means the evidence comes from retrospective cohorts rather than randomised trials, and B means the recommendation is moderate rather than strong.
About Helios
Helios helps clinicians move from a focused question to the literature that supports an answer. It keeps sources visible, surfaces uncertainty, and leaves the clinical decision where it belongs: with the clinician.
The team
CEO & Co-Founder
Former Technical Program Manager Lead at Google with 15 years of experience across AI, UX research, data operations, and product strategy
CSO & Co-Founder
PhD in Biomedical Science with expertise in translational research, applied to blood-based biomarker discovery and analytics in haematology and neurology
Founding Engineer
Senior Software Engineer with extensive experience on cloud infrastructure, RAG and agent development